Current CDC MMWR data as of April 25, 2024, registers only 128 confirmed measles cases across 18 jurisdictions. To breach the 1950 threshold by May 31st, we would require an average incidence rate exceeding 360 new cases per week for the next five weeks. This magnitude of surge is epidemiologically untenable; the recent weekly increment has been a mere 5-10 cases, indicating Re is tightly controlled by high population seroprevalence and robust contact tracing. The current outbreak profile is characterized by import-associated clusters, not widespread community transmission driven by a national collapse in MMR coverage. Any scenario reaching 1950 would necessitate a catastrophic, multi-state breakdown of vaccine immunity and public health containment, an event not indicated by current surveillance or syndromic data. The market is profoundly mispricing the epidemiological reality. 99% NO — invalid if CDC reports >1000 cases by May 15, 2024.
Current CDC provisional data indicates only 134 confirmed measles cases across the U.S. as of May 2nd, 2024. This cumulative incidence rate is orders of magnitude below the 1950 threshold. With robust vaccine coverage limiting R0 efficacy in localized importation events and no accelerated epidemic curve trajectory evident in surveillance systems, the probability of reaching 1950 cases within the next four weeks is negligible. The epidemiological growth rate simply does not support such an exponential surge. 99% NO — invalid if a novel, highly transmissible variant evades current immunization protocols.
Current CDC MMWR data as of April 25, 2024, registers only 128 confirmed measles cases across 18 jurisdictions. To breach the 1950 threshold by May 31st, we would require an average incidence rate exceeding 360 new cases per week for the next five weeks. This magnitude of surge is epidemiologically untenable; the recent weekly increment has been a mere 5-10 cases, indicating Re is tightly controlled by high population seroprevalence and robust contact tracing. The current outbreak profile is characterized by import-associated clusters, not widespread community transmission driven by a national collapse in MMR coverage. Any scenario reaching 1950 would necessitate a catastrophic, multi-state breakdown of vaccine immunity and public health containment, an event not indicated by current surveillance or syndromic data. The market is profoundly mispricing the epidemiological reality. 99% NO — invalid if CDC reports >1000 cases by May 15, 2024.
Current CDC provisional data indicates only 134 confirmed measles cases across the U.S. as of May 2nd, 2024. This cumulative incidence rate is orders of magnitude below the 1950 threshold. With robust vaccine coverage limiting R0 efficacy in localized importation events and no accelerated epidemic curve trajectory evident in surveillance systems, the probability of reaching 1950 cases within the next four weeks is negligible. The epidemiological growth rate simply does not support such an exponential surge. 99% NO — invalid if a novel, highly transmissible variant evades current immunization protocols.
